Retinoic acid induces apoptosis of prostate cancer DU145 cells through Cdk5 overactivation

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Chen, Mei Chih ^a   Huang, Chih Yang ^b,c   Hsu, Shih Lan ^d   Lin, Eugene ^a,e   Ku, Chien Te ^a   Lin, Ho ^a,c,f   Chen, Chuan Mu ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALPEPTIN; CASPASE 3; CYCLIN DEPENDENT KINASE 5; LIPOCORTIN 5; PROTEIN P25; PROTEIN P35; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CLEAVAGE;

EID: 84872130497     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/580736     Document Type: Article

References (53)

1. Rhim J. S., Kung H. F., Human prostate carcinogenesis. Critical Reviews in Oncogenesis 1997 8 4 305 328 2-s2.0-0031391412 (Pubitemid 28243521)
2. Hsu F. N., Yang M. S., Lin E., Tseng C. F., Lin H., The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. American Journal of Physiology- Endocrinology and Metabolism 2011 300 5 E902 E908 2-s2.0-79955563441 10.1152/ajpendo.00610.2010
3. Isaacs J. T., Isaacs W. B., Androgen receptor outwits prostate cancer drugs. Nature Medicine 2004 10 1 26 27 2-s2.0-1842612442 10.1038/nm0104-26 (Pubitemid 38524693)
4. Hellmich M. R., Pant H. C., Wada E., Battey J. F., Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proceedings of the National Academy of Sciences of the United States of America 1992 89 22 10867 10871 2-s2.0-0026452774 10.1073/pnas.89.22.10867
5. Dhavan R., Tsai L. H., A decade of CDK5. Nature Reviews Molecular Cell Biology 2001 2 10 749 759 2-s2.0-0035489777 10.1038/35096019 (Pubitemid 33679837)
6. Tsai L. H., Delalle I., Caviness V. S. Jr., Chae T., Harlow E., p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994 371 6496 419 423 2-s2.0-0027978170 10.1038/371419a0 (Pubitemid 24302556)
7. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L. H., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999 402 6762 615 622 2-s2.0-0033540060 10.1038/45159 (Pubitemid 129516324)
8. Lin H., Lin T. Y., Juang J. L., Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration. Cell Death and Differentiation 2007 14 3 607 615 2-s2.0-33847025578 10.1038/sj.cdd.4402033
9. Chen M. C., Lin H., Hsu F. N., Huang P. H., Lee G. S., Wang P. S., Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells. American Journal of Physiology-Cell Physiology 2010 299 2 C516 C527 2-s2.0-77955886121 10.1152/ajpcell.00534.2009
10. Strock C. J., Park J. I., Nakakura E. K., Bova G. S., Isaacs J. T., Ball D. W., Nelkin B. D., Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Research 2006 66 15 7509 7515 2-s2.0-33747875152 10.1158/0008-5472.CAN-05-3048 (Pubitemid 44289205)
11. Choi H. S., Lee Y., Park K. H., Sung J. S., Lee J. E., Shin E. S., Ryu J. S., Kim Y. H., Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population. Journal of Human Genetics 2009 54 5 298 303 2-s2.0-67649566961 10.1038/jhg.2009.29
12. Feldmann G., Mishra A., Hong S. M., Bisht S., Strock C. J., Ball D. W., Goggins M., Maitra A., Nelkin B. D., Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Research 2010 70 11 4460 4469 2-s2.0-77953149881 10.1158/0008-5472.CAN-09-1107
13. Lin H., The versatile roles of cyclin-dependent kinase 5 in human diseases. Adaptive Medicine 2009 1 1 22 25
14. Lin H., Chen M. C., Chiu C. Y., Song Y. M., Lin S. Y., Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. Journal of Biological Chemistry 2007 282 5 2776 2784 2-s2.0-34047251311 10.1074/jbc.M607234200 (Pubitemid 47084342)
15. Hsu F. N., Chen M. C., Chiang M. C., Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. Journal of Biological Chemistry 2011 286 38 33141 33149 10.1074/jbc.M111.252080
16. Lin H., Juang J. L., Wang P. S., Involvement of Cdk5/p25 in digoxin-triggered prostate-cancer cell apoptosis. Journal of Biological Chemistry 2004 279 28 29302 29307 2-s2.0-3142689920 10.1074/jbc.M403664200 (Pubitemid 38915807)
17. Kuo H. S., Hsu F. N., Chiang M. C., You S. C., Chen M. C., Lo M. J., Lin H., The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line. Chinese Journal of Physiology 2009 52 1 23 30 2-s2.0-70349554363 10.4077/CJP.2009.AMG067
18. Chomienne C., Fenaux P., Degos L., Retinoid differentiation therapy in promyelocytic leukemia. The FASEB Journal 1996 10 9 1025 1030 2-s2.0-0029838662 (Pubitemid 26285978)
19. Geisen C., Denk C., Kupper J. H., Schwarz E., Growth inhibition of cervical cancer cells by the human retinoic acid receptor beta gene. International Journal of Cancer 2000 85 2 289 295 (Pubitemid 30023081)
20. Hsu S. L., Chen M. C., Chou Y. H., Hwang G. Y., Yin S. C., Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Experimental Cell Research 1999 248 1 87 96 2-s2.0-0033541438 10.1006/excr.1999.4397 (Pubitemid 29393932)
21. Smith M. A., Parkinson D. R., Cheson B. D., Friedman M. A., Retinoids in cancer therapy. Journal of Clinical Oncology 1992 10 5 839 864 2-s2.0-0026682726
22. Um S. J., Kim E. J., Hwang E. S., Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. International Journal of Cancer 2000 85 3 416 423
23. Perlmann T., Retinoid metabolism: a balancing act. Nature Genetics 2002 31 1 7 8 2-s2.0-0036578794 10.1038/ng877
24. Maden M., Retinoic acid in the development, regeneration and maintenance of the nervous system. Nature Reviews Neuroscience 2007 8 10 755 765 2-s2.0-34648816863 10.1038/nrn2212 (Pubitemid 47462115)
25. Bollag W., Holdener E. E., Retinoids in cancer prevention and therapy. Annals of Oncology 1992 3 7 513 526 2-s2.0-0026750804
26. Huss W. J., Lai L., Barrios R. J., Hirschi K. K., Greenberg N. M., Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer. Prostate 2004 61 2 142 152 2-s2.0-4544361438 10.1002/pros.20097 (Pubitemid 39244701)
27. Toma S., Isnardi L., Raffo P., Effects of all-trans -retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction. International Journal of Cancer 1997 70 5 619 627 (Pubitemid 27149650)
28. Hsu S. L., Lin Y. F., Chou C. K., Transcriptional regulation of transferrin and albumin genes by retinoic acid in human hepatoma cell line Hep3B. Biochemical Journal 1992 283, part 2 611 615 2-s2.0-0026545292
29. McCormick D. L., Rao K. V. N., Steele V. E., Lubet R. A., Kelloff G. J., Bosland M. C., Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Cancer Research 1999 59 3 521 524 2-s2.0-0033082447 (Pubitemid 29076042)
30. Richter F., Huang H. F. S., Li M. T., Danielpour D., Wang S. L., Irwin R. J., Retinoid and androgen regulation of cell growth, epidermal growth factor and retinoic acid receptors in normal and carcinoma rat prostate cells. Molecular and Cellular Endocrinology 1999 153 1-2 29 38 2-s2.0-0033587589 10.1016/S0303-7207(99)00095-7 (Pubitemid 29339154)
31. Sun S. Y., Yue P., Lotan R., Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. Molecular Pharmacology 1999 55 3 403 410 2-s2.0-0033035635 (Pubitemid 29128096)
32. Trump D. L., Retinoids in bladder, testis and prostate cancer: epidemiologic, Pre-clinical and clinical observations. Leukemia 1994 8 3 S50 S54 2-s2.0-0028607257
33. Kelly W. K., Osman I., Reuter V. E., Curley T., Heston W. D. W., Nanus D. M., Scher H. I., The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. Clinical Cancer Research 2000 6 3 838 846 2-s2.0-0034103154 (Pubitemid 30159338)
34. Blutt S. E., Allegretto E. A., Pike J. W., Weigel N. L., 1,25-Dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 1997 138 4 1491 1497 2-s2.0-0030910440 10.1210/en.138.4.1491 (Pubitemid 27137098)
35. DiPaola R. S., Rafi M. M., Vyas V., Toppmeyer D., Rubin E., Patel J., Goodin S., Medina M., Medina P., Zamek R., Zhang C., White E., Gupta E., Hait W. N., Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies. Journal of Clinical Oncology 1999 17 7 2213 2218 2-s2.0-0033023218 (Pubitemid 29318855)
36. Lin H., Chen M. C., Ku C. T., Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells. Endocrinology 2009 150 1 396 403 2-s2.0-58149469225 10.1210/en.2008-0496
37. Jones Villeneuve E. M. V., Rudnicki M. A., Harris J. F., McBurney M. W., Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Molecular and Cellular Biology 1983 3 12 2271 2279 2-s2.0-0021035059 (Pubitemid 14224710)
38. Wang C. X., Song J. H., Song D. K., Yong V. W., Shuaib A., Hao C., Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death and Differentiation 2006 13 7 1203 1212 2-s2.0-33745192268 10.1038/sj.cdd.4401804 (Pubitemid 43905600)
39. Fu W. Y., Wang J. H., Ip N. Y., Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation. Journal of Neurochemistry 2002 81 3 646 654 2-s2.0-0036317176 10.1046/j.1471-4159.2002.00856.x (Pubitemid 34809343)
40. Lee J. H., Kim K. T., Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase a pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells. Journal of Neurochemistry 2004 91 3 634 647 2-s2.0-7244260747 10.1111/j.1471-4159.2004.02770.x (Pubitemid 39431158)
41. Hsu S. L., Wu W. S., Tyan Y. S., Chou C. K., Retinoic acid-induced apoptosis is prevented by serum albumin and enhanced by Lipiodol in human hepatoma Hep3B cells. Cancer Letters 1998 129 2 205 214 2-s2.0-0032547013 10.1016/S0304-3835(98)00100-1 (Pubitemid 28386603)
42. 2+ transport and cell activation. Medical Biology 1982 60 4 168 182 2-s2.0-0020334410 (Pubitemid 13253961)
43. McConkey D. J., Orrenius S., The role of calcium in the regulation of apoptosis. Biochemical and Biophysical Research Communications 1997 239 2 357 366 2-s2.0-0031581060 10.1006/bbrc.1997.7409 (Pubitemid 27488969)
44. Garattini E., Parrella E., Diomede L., Gianni M., Kalac Y., Merlini L., Simoni D., Zanier R., Ferrara F. F., Chiarucci I., Carminati P., Terao M., Pisano C., ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood 2004 103 1 194 207 2-s2.0-9144222122 10.1182/blood-2003-05- 1577 (Pubitemid 38029939)
45. Kim H., Lapointe J., Kaygusuz G., Ong D. E., Li C., van de Rijn M., Brooks J. D., Pollack J. R., The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Research 2005 65 18 8118 8124 2-s2.0-24944556612 10.1158/0008-5472.CAN-04-4562 (Pubitemid 41330574)
46. Campbell M. J., Park S., Uskokovic M. R., Dawson M. I., Koeffler H. P., Expression of retinoic acid receptor- β sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog. Endocrinology 1998 139 4 1972 1980 2-s2.0-0031762013 (Pubitemid 28513859)
47. Pasquali D., Chieffi P., Deery W. J., Nicoletti G., Bellastella A., Sinisi A. A., Differential effects of all-trans -retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells. European Journal of Endocrinology 2005 152 4 663 669 2-s2.0-17744390198 10.1530/eje.1.01875 (Pubitemid 40575813)
48. Esquenet M., Swinnen J. V., Heyns W., Verhoeven G., Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1 α25-dihydroxycholecalciferol, all-trans retinoic acid, 9-Cis retinoic acid, and phenylacetate. Prostate 1996 28 3 182 194 2-s2.0-0029966081
49. Pasquali D., Rossi V., Prezioso D., Gentile V., Colantuoni V., Lotti T., Bellastella A., Sinisi A. A., Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells. Journal of Clinical Endocrinology and Metabolism 1999 84 4 1463 1469 2-s2.0-0033342825 (Pubitemid 30644416)
50. Gao M., Ossowski L., Ferrari A. C., Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. Journal of Cellular Physiology 1999 179 3 336 346 (Pubitemid 29203158)
51. Nehmé A., Varadarajan P., Sellakumar G., Gerhold M., Niedner H., Zhang Q., Lin X., Christen R. D., Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells. British Journal of Cancer 2001 84 11 1571 1576 2-s2.0-0035365162 10.1054/bjoc.2001.1818 (Pubitemid 32579352)
52. Pili R., Kruszewski M. P., Hager B. W., Lantz J., Carducci M. A., Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis. Cancer Research 2001 61 4 1477 1485 2-s2.0-0035866341 (Pubitemid 34292576)
53. Gillis J. C., Goa K. L., Tretinoin: a review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia. Drugs 1995 50 5 897 923 2-s2.0-0028849186